Sei Investments CO Sangamo Therapeutics, Inc Transaction History

Sei Investments CO

$69 Billion
Q2 2024

A detailed history of Sei Investments CO transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Sei Investments CO holds 21,047 shares of SGMO stock, worth $18,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,047

Previous 21,047 -0.0%

Holding current value

$18,100

Previous $14,000 50.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.3 - $0.63 $6,041 - $12,686	-20,138 Reduced 48.9%	21,047 $11,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $5,471 - $13,866	-9,433 Reduced 18.64%	41,185 $24,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $29,855 - $46,800	26,897 Added 113.39%	50,618 $65,000
Q1 2023 May 12, 2023	BUY	$1.66 - $3.67 $4,940 - $10,921	2,976 Added 14.35%	23,721 $41,000
Q4 2022 Feb 10, 2023	SELL	$2.77 - $5.07 $271 - $496	-98 Reduced 0.47%	20,745 $65,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $88,999 - $133,186	20,843 New	20,843 $102,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.21 $67,682 - $128,143	-20,635 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $1,563 - $2,338	299 Added 1.47%	20,635 $61,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $3,732 - $5,616	-512 Reduced 2.46%	20,336 $98,000
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $3,712 - $4,948	412 Added 2.02%	20,848 $148,000
Q2 2021 Aug 06, 2021	SELL	$10.17 - $12.64 $3,996 - $4,967	-393 Reduced 1.89%	20,436 $255,000
Q4 2020 Feb 08, 2021	SELL	$9.23 - $18.18 $808,234 - $1.59 Million	-87,566 Reduced 80.78%	20,829 $371,000
Q3 2020 Dec 04, 2020	SELL	$9.38 - $12.48 $265,763 - $353,595	-28,333 Reduced 20.72%	108,395 $1.07 Million
Q3 2020 Nov 06, 2020	BUY	$9.38 - $12.48 $660,727 - $879,091	70,440 Added 106.26%	136,728 $1.34 Million
Q2 2020 Aug 17, 2020	SELL	$6.21 - $11.83 $198,123 - $377,424	-31,904 Reduced 32.49%	66,288 $648,000
Q2 2020 Aug 11, 2020	BUY	$6.21 - $11.83 $609,772 - $1.16 Million	98,192 New	98,192 $915,000
Q1 2020 May 14, 2020	SELL	$5.05 - $8.85 $161,115 - $282,350	-31,904 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$8.03 - $11.7 $256,189 - $373,276	31,904 New	31,904 $267,000
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $1,474 - $2,446	-191 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$13.05 - $19.05 $926 - $1,352	71 Added 59.17%	191 $3,000
Q2 2018 Aug 03, 2018	BUY	$13.9 - $19.8 $1,668 - $2,376	120 New	120 $2,000

Others Institutions Holding SGMO

# of Institutions

133

Shares Held

86.3M

Call Options Held

35.9K

Put Options Held

156K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $135M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Sangamo Therapeutics, Inc Transaction History